|
|
|
THE PLANAR CELL POLARITY WNT SIGNALING PATHWAY (PW:0000200)
DescriptionThe planar cell polarity Wnt signaling pathway (PCP) plays a major role in embryonic tissue patterning, cell polarization, migration and morphogenesis. The PCP pathway, along with the Wnt-calcium pathway, belongs to the non-canonical Wnt signaling in that is independent of beta-catenin, the core component of the canonical Wnt pathway. The PCP pathway is less well understood and characterized but evidence is rapidly accumulating establishing the core components and the role they play, the common denominators and the distinctions between Drosophila and vertebrates. Frizzled receptors (Fzd) and the intracellular dishevelled (Dvl), the latter representing the branching point between canonical and non-canonical pathways, are necessary components. A requirement for Wnt ligands is controversial but some, like Wnt5, Wnt7 and Wnt11 appear to play a role, at least in vertebrates. Other core components include the membrane proteins Vangl2 (Strabismus/Van Gogh homolog) and Celsr1 (Flamingo homolog) and the cytoplasmic Prickle. Additional members of the vertebrate PCP pathway include Ptk7 and Scrib and the downstream effector Daam1. The asymmetric and polarized membrane association of PCP components has been established in Drosophila; a similar, yet distinct pattern has been observed in mammals. Scrib interacting with Vangl2 plays a role in the asymmetric positioning of Vangl2 (interaction mediated by the PDZ domains of the two proteins, a domain also shared by the modular dishevelled); Celsr1 also contributes to the asymmetric localization of Vangl2. Ptk7 also appears to interact with Vangl2 but this interaction plays, remains to be established. Vangl can recruit Prickle which then can bind to and antagonize Dvl recruitment by Fzd. Activation of Fzd and recruitment of Dvl leads to activation of the members of the Rho family of small monomeric G proteins RhoA ¿ via interaction with Daam1, and Rac and subsequent triggering of Rho/Rac/Cdc42 and C-Jun N-terminal kinase (JNK) pathways. The former pathway controls cytoskeletal rearrangements and organization and the latter impacts on gene expression. Deregulation of the pathway has been implicated in a number of human diseases including cancer. To see the ontology report for annotations, GViewer and download, click here[click to see the ontology report for related GO term - GO:0060071 and KEGG map - map04310] ...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
the planar cell polarity Wnt signaling pathway
|
| G |
Cdk15 |
cyclin-dependent kinase 15 |
|
|
IEP |
9 |
57,840,625 |
57,930,096 |
RGD:2292645 |
RGD |
| G |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
|
|
ISS |
7 |
123,900,366 |
124,036,122 |
RGD:2293492 |
RGD |
| G |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
|
|
ISS |
6 |
94,081,666 |
94,184,202 |
RGD:2293492 |
RGD |
| G |
Dvl1 |
dishevelled segment polarity protein 1 |
|
|
ISS |
5 |
172,705,951 |
172,717,626 |
RGD:1581694 |
RGD |
| G |
Dvl2 |
dishevelled segment polarity protein 2 |
|
|
ISS |
|
|
|
RGD:2293492 |
RGD |
| G |
Fzd3 |
frizzled family receptor 3 |
|
|
ISS |
|
|
|
RGD:2293492 |
RGD |
| G |
Fzd6 |
frizzled family receptor 6 |
|
|
ISS |
7 |
74,562,307 |
74,594,014 |
RGD:2293492 |
RGD |
| G |
Fzd9 |
frizzled family receptor 9 |
|
|
IEP |
12 |
22,581,510 |
22,583,824 |
RGD:2292645 |
RGD |
| G |
Prickle1 |
prickle homolog 1 (Drosophila) |
|
|
ISS |
7 |
131,967,220 |
131,986,187 |
RGD:2293492 |
RGD |
| G |
Prickle2 |
prickle homolog 2 (Drosophila) |
|
|
ISS |
4 |
126,571,461 |
126,920,730 |
RGD:2293492 |
RGD |
| G |
Ptk7 |
protein tyrosine kinase 7 |
|
|
ISS |
|
|
|
RGD:2293492 |
RGD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
|
ISS |
12 |
11,380,314 |
11,400,531 |
RGD:1581694 |
RGD |
| G |
Rhoa |
ras homolog family member A |
|
|
ISS |
|
|
|
RGD:2302030 |
RGD |
| G |
Scrib |
scribbled planar cell polarity protein |
|
|
ISS |
7 |
114,077,733 |
114,100,721 |
RGD:2293492 |
RGD |
| G |
Vangl2 |
VANGL planar cell polarity protein 2 |
|
|
ISS |
13 |
87,964,426 |
87,988,364 |
RGD:2293492 |
RGD |
| G |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
|
|
IMP |
7 |
123,533,713 |
123,554,333 |
RGD:2292645 |
RGD |
| G |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
|
|
ISS |
7 |
123,533,713 |
123,554,333 |
RGD:1581694 |
RGD |
|
|
|
Pathway Gene Annotations |
|
Disease Annotations Associated with Genes in the the planar cell polarity Wnt signaling pathway
|
|
|
|
| Cdk15 | Wilms Tumor | |
|
| Dvl1 | DiGeorge Syndrome , Myocardial Infarction , Schizophrenia | |
| Fzd3 | Schizophrenia , Williams Syndrome | |
|
| Prickle1 | Epilepsy, Progressive Myoclonic, 1b | |
|
| Rac1 | Cardiomegaly , Heart Failure , Hypertrophy, Left Ventricular | | Rhoa | Asthma , Brain Injuries , Breast Neoplasms , Cardiomegaly , Colorectal Neoplasms , Diabetes Mellitus, Experimental , Encephalomyelitis, Autoimmune, Experimental , Fetal Alcohol Syndrome , Fibrosis , Glomerulonephritis, Membranous , Hypertension , Hypertension, Pulmonary , Hypertrophy, Left Ventricular , Liver Cirrhosis, Experimental , Lymphatic Metastasis , Multiple Sclerosis , Myocardial Reperfusion Injury , Neoplasm Metastasis , Neoplasms, Germ Cell and Embryonal , Neuritis, Autoimmune, Experimental , Obesity , Optic Nerve Injuries , Ovarian Neoplasms , Urinary Bladder Neoplasms , Urologic Neoplasms | |
| Vangl2 | Kidney Neoplasms | | Wnt7b | Breast Neoplasms , Mammary Neoplasms, Experimental , Urinary Bladder Neoplasms | |
| Fetal Alcohol Syndrome | Rhoa | | Obesity | Rhoa | | Cardiomegaly | Rac1 , Rhoa | | Hypertension, Pulmonary | Rhoa | | Ovarian Neoplasms | Rhoa | | Breast Neoplasms | Rhoa , Wnt7b | | Wilms Tumor | Cdk15 | | Urinary Bladder Neoplasms | Rhoa , Wnt7b | | Fibrosis | Rhoa | | Colorectal Neoplasms | Rhoa | | Hypertension | Rhoa | | Kidney Neoplasms | Vangl2 | | Neoplasms, Germ Cell and Embryonal | Rhoa | | DiGeorge Syndrome | Dvl1 | | Asthma | Rhoa | | Urologic Neoplasms | Rhoa | | Brain Injuries | Rhoa | | Diabetes Mellitus, Experimental | Rhoa | | Heart Failure | Rac1 | | Encephalomyelitis, Autoimmune, Experimental | Rhoa | | Liver Cirrhosis, Experimental | Rhoa | | Lymphatic Metastasis | Rhoa | | Neoplasm Metastasis | Rhoa | | Mammary Neoplasms, Experimental | Wnt7b | | Multiple Sclerosis | Rhoa | | Myocardial Infarction | Dvl1 | | Neuritis, Autoimmune, Experimental | Rhoa | | Schizophrenia | Dvl1 , Fzd3 | | Myocardial Reperfusion Injury | Rhoa | | Glomerulonephritis, Membranous | Rhoa | | Hypertrophy, Left Ventricular | Rac1 , Rhoa | | Williams Syndrome | Fzd3 | | Optic Nerve Injuries | Rhoa | | Epilepsy, Progressive Myoclonic, 1b | Prickle1 | |
|